Literature DB >> 23737137

Matrix metalloproteinase-2 (MMP-2) generates soluble HLA-G1 by cell surface proteolytic shedding.

Roberta Rizzo1, Alessandro Trentini, Daria Bortolotti, Maria C Manfrinato, Antonella Rotola, Massimiliano Castellazzi, Loredana Melchiorri, Dario Di Luca, Franco Dallocchio, Enrico Fainardi, Tiziana Bellini.   

Abstract

Human leukocyte antigen-G (HLA-G) molecules are non-classical HLA class I antigens with an important role in pregnancy immune regulation and inflammation control. Soluble HLA-G proteins can be generated through two mechanisms: alternative splicing and proteolytic release, which is known to be metalloprotease mediated. Among this class of enzymes, matrix metalloproteinases (MMPs) might be involved in the HLA-G1 membrane cleavage. Of particular interest are MMP-2 and MMP-9, which regulate the inflammatory process by cytokine and chemokine modulation. We evaluated the effect of MMP-9 and MMP-2 on HLA-G1 membrane shedding. In particular, we analyzed the in vitro effect of these two gelatinases on the secretion of HLA-G1 via proteolytic cleavage in 221-G1-transfected cell line, in JEG3 cell line, and in peripheral blood mononuclear cells. The results obtained by both cell lines showed the role of MMP-2 in HLA-G1 shedding. On the contrary, MMP-9 was not involved in this process. In addition, we identified three possible highly specific cleavage sites for MMP-2, whereas none were detected for MMP-9. This study suggests an effective link between MMP-2 and HLA-G1 shedding, increasing our knowledge on the regulatory machinery beyond HLA-G regulation in physiological and pathological conditions.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23737137     DOI: 10.1007/s11010-013-1708-5

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  71 in total

1.  Cutting edge: soluble HLA-G1 triggers CD95/CD95 ligand-mediated apoptosis in activated CD8+ cells by interacting with CD8.

Authors:  S Fournel; M Aguerre-Girr; X Huc; F Lenfant; A Alam; A Toubert; A Bensussan; P Le Bouteiller
Journal:  J Immunol       Date:  2000-06-15       Impact factor: 5.422

2.  Implication of HLA-G molecule in heart-graft acceptance.

Authors:  N Lila; A Carpentier; C Amrein; I Khalil-Daher; J Dausset; E D Carosella
Journal:  Lancet       Date:  2000-06-17       Impact factor: 79.321

Review 3.  Gelatinase B: a tuner and amplifier of immune functions.

Authors:  G Opdenakker; P E Van den Steen; J Van Damme
Journal:  Trends Immunol       Date:  2001-10       Impact factor: 16.687

Review 4.  Matrix metalloproteinases, their production by monocytes and macrophages and their potential role in HIV-related diseases.

Authors:  Nicole L Webster; Suzanne M Crowe
Journal:  J Leukoc Biol       Date:  2006-09-07       Impact factor: 4.962

5.  Western blot of proteins from Coomassie-stained polyacrylamide gels.

Authors:  V Ranganathan; P K De
Journal:  Anal Biochem       Date:  1996-02-01       Impact factor: 3.365

6.  Differentiation of type 1 T regulatory cells (Tr1) by tolerogenic DC-10 requires the IL-10-dependent ILT4/HLA-G pathway.

Authors:  Silvia Gregori; Daniela Tomasoni; Valentina Pacciani; Miriam Scirpoli; Manuela Battaglia; Chiara Francesca Magnani; Ehud Hauben; Maria-Grazia Roncarolo
Journal:  Blood       Date:  2010-05-06       Impact factor: 22.113

7.  HLA-G has a concentration-dependent effect on the generation of an allo-CTL response.

Authors:  K Kapasi; S E Albert; S Yie; N Zavazava; C L Librach
Journal:  Immunology       Date:  2000-10       Impact factor: 7.397

8.  Increase in HLA-G1 proteolytic shedding by tumor cells: a regulatory pathway controlled by NF-kappaB inducers.

Authors:  I Zidi; C Guillard; C Marcou; I Krawice-Radanne; D Sangrouber; N Rouas-Freiss; E D Carosella; P Moreau
Journal:  Cell Mol Life Sci       Date:  2006-11       Impact factor: 9.261

9.  Soluble beta 2-microglobulin-free class I heavy chains are released from the surface of activated and leukemia cells by a metalloprotease.

Authors:  S Demaria; R Schwab; S R Gottesman; Y Bushkin
Journal:  J Biol Chem       Date:  1994-03-04       Impact factor: 5.157

10.  A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells.

Authors:  M Colonna; F Navarro; T Bellón; M Llano; P García; J Samaridis; L Angman; M Cella; M López-Botet
Journal:  J Exp Med       Date:  1997-12-01       Impact factor: 14.307

View more
  30 in total

1.  Basis for substrate recognition and distinction by matrix metalloproteinases.

Authors:  Boris I Ratnikov; Piotr Cieplak; Kosi Gramatikoff; James Pierce; Alexey Eroshkin; Yoshinobu Igarashi; Marat Kazanov; Qing Sun; Adam Godzik; Andrei Osterman; Boguslaw Stec; Alex Strongin; Jeffrey W Smith
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-22       Impact factor: 11.205

2.  ADAM17 cleaves the insulin receptor ectodomain on endothelial cells and causes vascular insulin resistance.

Authors:  Thaysa Ghiarone; Jorge A Castorena-Gonzalez; Christopher A Foote; Francisco I Ramirez-Perez; Larissa Ferreira-Santos; Francisco J Cabral-Amador; Roger de la Torre; Rama R Ganga; Andrew A Wheeler; Camila Manrique-Acevedo; Jaume Padilla; Luis A Martinez-Lemus
Journal:  Am J Physiol Heart Circ Physiol       Date:  2022-08-26       Impact factor: 5.125

3.  Downregulated cytotoxic CD8+ T-cell identifies with the NKG2A-soluble HLA-E axis as a predictive biomarker and potential therapeutic target in keloids.

Authors:  Heng Xu; Zhu Zhu; Jian Hu; Jiawei Sun; Yan Wo; Xianshu Wang; Hongzhi Zou; Bin Li; Yixin Zhang
Journal:  Cell Mol Immunol       Date:  2022-01-17       Impact factor: 22.096

4.  Human Leukocyte Antigen-G (HLA-G) Expression in Cancers: Roles in Immune Evasion, Metastasis and Target for Therapy.

Authors:  Aifen Lin; Wei-Hua Yan
Journal:  Mol Med       Date:  2015-08-24       Impact factor: 6.354

Review 5.  Contribution of the plasma and lymph Degradome and Peptidome to the MHC Ligandome.

Authors:  Laura Santambrogio; Hans-Georg Rammensee
Journal:  Immunogenetics       Date:  2018-10-20       Impact factor: 2.846

6.  HLA-G expression levels influence the tolerogenic activity of human DC-10.

Authors:  Giada Amodio; Michela Comi; Daniela Tomasoni; Monica Emma Gianolini; Roberta Rizzo; Joël LeMaoult; Maria-Grazia Roncarolo; Silvia Gregori
Journal:  Haematologica       Date:  2015-02-06       Impact factor: 9.941

Review 7.  HLA-G Orchestrates the Early Interaction of Human Trophoblasts with the Maternal Niche.

Authors:  Silvia Gregori; Giada Amodio; Federica Quattrone; Paola Panina-Bordignon
Journal:  Front Immunol       Date:  2015-03-30       Impact factor: 7.561

Review 8.  Role of non-classical MHC class I molecules in cancer immunosuppression.

Authors:  Grazyna Kochan; David Escors; Karine Breckpot; David Guerrero-Setas
Journal:  Oncoimmunology       Date:  2013-10-21       Impact factor: 8.110

9.  HLA-G dimers in the prolongation of kidney allograft survival.

Authors:  Maureen Ezeakile; Vera Portik-Dobos; Juan Wu; Daniel D Horuzsko; Rajan Kapoor; Muralidharan Jagadeesan; Laura L Mulloy; Anatolij Horuzsko
Journal:  J Immunol Res       Date:  2014-03-30       Impact factor: 4.818

Review 10.  Some basic aspects of HLA-G biology.

Authors:  Estibaliz Alegre; Roberta Rizzo; Daria Bortolotti; Sara Fernandez-Landázuri; Enrico Fainardi; Alvaro González
Journal:  J Immunol Res       Date:  2014-04-09       Impact factor: 4.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.